The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
Anti-Bacterial Agents
/ administration & dosage
Critical Care
/ methods
Critical Illness
Cross-Sectional Studies
Drug Monitoring
/ methods
Germany
Humans
Intensive Care Units
Meropenem
/ administration & dosage
Microbial Sensitivity Tests
Physicians
/ psychology
Piperacillin
/ administration & dosage
Surveys and Questionnaires
Treatment Outcome
Vancomycin
/ administration & dosage
Beta-lactams
Intensive care unit
Minimal inhibitory concentration
Pharmacokinetics/pharmacodynamics
Survey
Therapeutic drug monitoring
Journal
Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
14
07
2020
revised:
27
08
2020
accepted:
30
08
2020
pubmed:
16
9
2020
medline:
27
5
2021
entrez:
15
9
2020
Statut:
ppublish
Résumé
Optimization of antibiotic therapy is still urgently needed in critically ill patients. The aim of the ONTAI survey (online survey on the use of Therapeutic Drug Monitoring of antibiotics in intensive care units) was to evaluate which strategies intensive care physicians in Germany use to improve the quality of antibiotic therapy and what role a Therapeutic Drug Monitoring (TDM) plays. Among the members of the German Society for Anaesthesiology and the German Society for Medical Intensive Care Medicine and Emergency Medicine, a national cross-sectional survey was conducted using an online questionnaire. The questionnaire was completely answered by 398 respondents. Without TDM, prolonged infusion was judged to be the most appropriate dosing regimen for beta lactams. A TDM for piperacillin, meropenem and vancomycin was performed in 17, 22 and 75% of respondents, respectively. For all beta lactams, a TDM was requested more often than it was available. There was great uncertainty as to the optimal pharmacokinetic/pharmacodynamic index for beta-lactams. 86% of the respondents who received minimal inhibitory concentrations adapted the therapy accordingly. German intensive care physicians are convinced of TDM for dose optimization. However, practical implementation, the determination of MICs and defined target values are still lacking.
Identifiants
pubmed: 32932111
pii: S0883-9441(20)30677-8
doi: 10.1016/j.jcrc.2020.08.027
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Vancomycin
6Q205EH1VU
Meropenem
FV9J3JU8B1
Piperacillin
X00B0D5O0E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
260-266Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no competing interests.